# BYND — baseline

## Metadata

ticker: BYND
arm: baseline
judge_prompt_version: v2
context_sha256: 8a95be69936b103e290f40a52c1b9ca4635660f7e6880d6f29321e018237a896
llm_calls: 7
llm_endpoints: anthropic
llm_by_site: {"rag:highlights": {"calls": 1, "completion_tokens": 180, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 2.275, "latency_s_total": 2.275, "parse_failure": 0, "prompt_tokens": 3224, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "rag:risks": {"calls": 1, "completion_tokens": 321, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 4.983, "latency_s_total": 4.983, "parse_failure": 0, "prompt_tokens": 3197, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "section:financial_health": {"calls": 1, "completion_tokens": 194, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 2.394, "latency_s_total": 2.394, "parse_failure": 0, "prompt_tokens": 656, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "section:recent_developments": {"calls": 1, "completion_tokens": 183, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 2.356, "latency_s_total": 2.356, "parse_failure": 0, "prompt_tokens": 649, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "section:risk_factors": {"calls": 1, "completion_tokens": 157, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 1.868, "latency_s_total": 1.868, "parse_failure": 0, "prompt_tokens": 394, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "section:sec_filing_highlights": {"calls": 1, "completion_tokens": 105, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 1.238, "latency_s_total": 1.238, "parse_failure": 0, "prompt_tokens": 261, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "synthesis": {"calls": 1, "completion_tokens": 1113, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 16.45, "latency_s_total": 16.45, "parse_failure": 0, "prompt_tokens": 1682, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}}

## Retrieved source context

STOCK DATA:
{
  "ticker": "BYND",
  "company_name": "Beyond Meat, Inc.",
  "current_price": 8.06,
  "currency": "USD",
  "market_cap": 138583360.0,
  "forward_pe": -0.773186,
  "week_52_high": 230.7,
  "week_52_low": 7.84,
  "financial_currency": "USD",
  "revenue": 258844992.0,
  "net_income": 258864992.0,
  "profit_margin_pct": 115.85,
  "dividend_yield": 0.0,
  "sector": "Consumer Defensive",
  "industry": "Packaged Foods"
}

NEWS ARTICLES:
[
  {
    "title": null,
    "source": null,
    "published_at": null,
    "description": null
  }
]

SEC FILING SUMMARIES:
{
  "10-K": {
    "form_type": "10-K",
    "filing_date": "2026-04-09",
    "summary": "ITEM 1A. RISK FACTORS. Risk Factor Summary We are providing the following summary of the risk factors to enhance the readability and accessibility of our risk factor disclosures. We encourage you to carefully review the full risk factors immediately following this summary as well as the other information in this report, including Item 7 , Management\u2019s Discussion and Analysis of Financial Condition and Results of Operations , Note Regarding Forward-Looking Statements , and our consolidated financial statements and related notes, before deciding whether to invest in shares of our common stock. The risks and uncertainties described in this report may not be the only ones we face. If any of the risks actually occurs, our business, financial condition, operating results, cash flows and prospect"
  },
  "10-Q": {
    "form_type": "10-Q",
    "filing_date": "2026-08-06",
    "summary": "ITEM 1A. RISK FACTORS. In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, Item 1A, Risk Factors, in our 2025 10-K, as updated and supplemented below and in our subsequent filings. These risks could materially harm our business, operating results and financial condition. Additional factors and uncertainties not currently known to us or that we currently consider immaterial also may materially adversely affect our business, financial condition or future results. Risk Factors Risks Related to Our Business Our strategic repositioning to \u201cBeyond The Plant Protein Company\u201d may not be successful, and our failure to effectively execute or realize the anticipated benefits of this strategy could have a material adverse effect"
  }
}

RAG — SEC HIGHLIGHTS:
[From Pinecone cache] I cannot provide a summary of the latest 10-K and 10-Q based on the information provided. The context only contains risk factor disclosures from a filing, which represent just one section of these comprehensive documents.

To properly summarize the key takeaways from a 10-K or 10-Q, I would need access to additional sections such as:

- Management's Discussion and Analysis (MD&A)
- Financial statements and results of operations
- Business overview and strategy
- Executive compensation
- Market data and performance metrics

The risk factors alone do not provide a complete picture of the company's financial performance, strategic direction, or overall business status. If you'd like, I can summarize the specific risk factors that are disclosed in the provided context, or you could provide additional sections from the filing for a more comprehensive analysis.

RAG — RISK FACTORS:
[From Pinecone cache] # Primary Risk Factors Disclosed

The company discloses risk factors across three main categories:

## Risks Related to Business Operations
- Adverse economic and political conditions, including inflation concerns, government shutdowns, and trade policy uncertainties
- History of losses and negative cash flows, with challenges in achieving sustained profitability
- Weakness in the plant-based meat category with ongoing demand declines
- Operational challenges including cost-reduction initiatives, workforce reductions, and leadership changes
- Demand forecasting and capacity utilization difficulties
- Inventory management challenges, including potential liquidation at lower prices
- Supply chain disruptions and reliance on limited suppliers and distributors
- Customer consolidation and loss of significant customers
- Manufacturing facility disruptions
- Revenue growth challenges and seasonal fluctuations
- Talent retention and labor relations issues
- Integration risks from acquisitions and investments
- Technological changes and workplace safety risks

## Risks Related to Products
- Food safety incidents and product misbranding
- Declining sales of flagship products
- Changing consumer preferences
- Product innovation failures
- Price volatility and ingredient cost fluctuations

## Risks Related to Industry and Brand
- Increased competition and new market entrants
- Industry consolidation
- Brand reputation damage from quality or health concerns
- Failure to develop and maintain brand strength

Additionally, geopolitical risks including trade wars, tariffs, and international conflicts are highlighted as significant threats to supply chains, pricing, and market access.

## Pre-written sections (judge input)

### Financial Health

Beyond Meat is trading at $8.06 with a market capitalization of $138.6 million, representing a significant decline from its 52-week high of $230.70. The company's financial metrics are highly distorted, with a reported profit margin of 115.85% and net income of $258.9 million against revenue of $258.8 million, suggesting potential accounting anomalies or one-time gains that warrant careful scrutiny. The negative forward P/E ratio (-0.77) reflects unprofitability on a forward-looking basis despite the reported historical profitability. With no dividend yield and substantial operational challenges outlined in recent SEC filings regarding strategic repositioning, the company faces significant execution risk. Investors should exercise caution given the stock's 96% decline from its 52-week high and the company's acknowledged business transformation uncertainties.

### Recent Developments

Beyond Meat's recent SEC filings reveal significant strategic repositioning challenges as the company attempts to rebrand as "Beyond The Plant Protein Company," with management acknowledging material execution risks in this transformation. The company's financial metrics show concerning trends, including a negative forward P/E ratio and a stock price of $8.06—near its 52-week low of $7.84—reflecting investor skepticism about the turnaround strategy. With a market cap of approximately $139 million and reported net income exceeding revenue (suggesting accounting adjustments or one-time gains), the company faces substantial headwinds in demonstrating sustainable profitability. The lack of recent positive news developments, combined with explicit risk factor disclosures about strategic execution, suggests investors should closely monitor upcoming quarterly results for evidence that the repositioning strategy is gaining traction.

### SEC Filing Highlights

Unable to provide SEC filing highlights at this time. The available data contains only risk factor disclosures from Beyond Meat's filings, which is insufficient to summarize key financial performance, operational results, or strategic developments. A comprehensive analysis would require access to the Management's Discussion and Analysis (MD&A) section, financial statements, and results of operations. Please provide additional sections from the most recent 10-K or 10-Q for a complete investment brief.

### Risk Factors

• **Sustained Unprofitability and Negative Cash Flow** – Beyond Meat has a history of losses and negative cash flows with challenges achieving sustained profitability, compounded by ongoing cost-reduction initiatives and workforce reductions that may limit growth investments.

• **Declining Plant-Based Meat Category Demand** – The broader plant-based meat market is experiencing weakness with ongoing demand declines, creating headwinds for revenue growth regardless of company-specific performance.

• **Supply Chain Vulnerabilities and Customer Concentration** – The company faces supply chain disruptions, reliance on limited suppliers and distributors, and customer consolidation risks, with potential loss of significant customers that could materially impact revenues.

## Audited (Exec Summary + Outlook)

### Executive Summary
Beyond Meat is a plant-based meat alternative company trading at $8.06 with a market capitalization of $138.6 million — a fraction of its former scale, as reflected in its 96% decline from its 52-week high of $230.70 — and is currently attempting a strategic rebrand as "Beyond The Plant Protein Company" amid a broadly weakening plant-based meat category. The stock is notable now because it is trading near its 52-week low of $7.84, financial metrics are distorted by what appear to be one-time accounting gains, and management has explicitly disclosed material execution risks around its repositioning strategy, leaving the investment case deeply uncertain. The single most important near-term variable is whether upcoming quarterly results provide credible evidence that the rebranding and repositioning strategy is translating into operational traction — without that signal, investor skepticism is unlikely to abate.

### Outlook
The directional outlook for Beyond Meat is **cautious**. The company faces compounding headwinds: a structurally weakening plant-based meat category, a forward earnings profile that remains negative, a history of losses and negative cash flows, and a rebranding initiative that management itself has flagged as carrying material execution risk. Investors should monitor several key variables to assess whether the thesis can improve — most critically, whether quarterly results show stabilization or recovery in revenue trends, whether cost-reduction initiatives are improving underlying operating performance without further constraining the company's ability to invest in growth, and whether the "Beyond The Plant Protein Company" repositioning generates measurable consumer or retail partner response. On the supply side, watch for any deterioration in supplier or distributor relationships, and on the demand side, watch for signs that category-level weakness is bottoming or deepening. What would shift the view toward a more constructive stance is clear evidence of sustainable operational improvement, reduced reliance on one-time accounting items to support reported profitability, and demonstrated traction in the repositioning strategy over consecutive quarters — none of which is visible in the current data.

---
*This brief is for informational purposes only and does not constitute financial advice.*

## Judge findings

I will now systematically audit every specific quantitative figure, price target, threshold, ratio, metric, percentage, named product milestone, or forward-looking number in the Executive Summary and Outlook sections.

---

**EXECUTIVE SUMMARY**

---

CLAIM: "trading at $8.06"
LABEL: SUPPORTED
REASON: The raw source data explicitly lists `"current_price": 8.06`.

---

CLAIM: "market capitalization of $138.6 million"
LABEL: SUPPORTED
REASON: Source data shows `"market_cap": 138583360.0`, which rounds to $138.6 million.

---

CLAIM: "96% decline from its 52-week high of $230.70"
LABEL: SUPPORTED
REASON: Source data confirms `"week_52_high": 230.7`; the decline is (230.70 − 8.06) / 230.70 = 96.51%, which rounds to 96% — within acceptable rounding; both the percentage and the high figure are verified.

---

CLAIM: "52-week high of $230.70"
LABEL: SUPPORTED
REASON: Source data explicitly states `"week_52_high": 230.7`.

---

CLAIM: "trading near its 52-week low of $7.84"
LABEL: SUPPORTED
REASON: Source data confirms `"week_52_low": 7.84`; current price of $8.06 is $0.22 above the low, which is arithmetically near the low, and the low figure itself is present in the source data.

---

CLAIM: "financial metrics are distorted by what appear to be one-time accounting gains"
LABEL: SUPPORTED
REASON: The pre-written Financial Health section explicitly states "suggesting potential accounting anomalies or one-time gains that warrant careful scrutiny," grounding this characterization in the source material.

---

CLAIM: "management has explicitly disclosed material execution risks around its repositioning strategy"
LABEL: SUPPORTED
REASON: The 10-Q summary explicitly states "our failure to effectively execute or realize the anticipated benefits of this strategy could have a material adverse effect," confirming management's explicit disclosure of material execution risk.

---

**OUTLOOK**

---

CLAIM: "forward earnings profile that remains negative"
LABEL: SUPPORTED
REASON: Source data shows `"forward_pe": -0.773186`, confirming a negative forward P/E, which indicates a negative forward earnings profile.

---

CLAIM: "a history of losses and negative cash flows"
LABEL: SUPPORTED
REASON: The RAG Risk Factors section explicitly states "History of losses and negative cash flows, with challenges in achieving sustained profitability."

---

CLAIM: "a rebranding initiative that management itself has flagged as carrying material execution risk"
LABEL: SUPPORTED
REASON: The 10-Q filing summary explicitly states the strategic repositioning "may not be successful" and that "failure to effectively execute or realize the anticipated benefits of this strategy could have a material adverse effect," confirming management's own flagging of material execution risk.

---

CLAIM: "the 'Beyond The Plant Protein Company' repositioning"
LABEL: SUPPORTED
REASON: The 10-Q filing summary explicitly names the strategic repositioning to "Beyond The Plant Protein Company."

---

CLAIM: "reduced reliance on one-time accounting items to support reported profitability"
LABEL: INFERENCE
REASON: No one-time items are explicitly named or quantified in the source data, but the claim is a direct restatement of the pre-written section's observation that net income ($258.9M) exceeding revenue ($258.8M) suggests accounting anomalies or one-time gains — the directional inference is fully derivable from those two figures without any additional facts.

---

**Summary of findings:** All quantitative figures in the Executive Summary and Outlook are either directly present in the source data or arithmetically derivable from it. No claims are UNSUPPORTED. One forward-looking qualitative claim about "one-time accounting items" is labeled INFERENCE as it is a restatement of an observation derivable from the anomalous net income/revenue relationship visible in the data.
